Top Markets
Coin of the day
Bioray Biotech Co., Ltd Bioray Biotech Co., Ltd

Bioray Biotech Co., Ltd

7561
Rank in Stocks #30627
Bioray Biotech Co., Ltd is dedicated to the innovation, manufacturing, and... Bioray Biotech Co., Ltd is dedicated to the innovation, manufacturing, and distribution of biological and health supplement products. The company's biological offerings span specialized functional probiotics, therapeutic fungi, and immune cell preparations. Additionally, Bioray Biotech extends its expertise to the field of cellular testing and preservation services. Founded in 1994, this Taiwanese firm is based in Pingtung.
Share Price
$0.54376338
Market Cap
$16.09M
Change (1 day)
0.00%
Change (1 year)
-37.90%
Country
TW
Trade Bioray Biotech Co., Ltd (7561)

Category

P/E ratio for Bioray Biotech Co., Ltd (7561)
P/E ratio as of 2026 TTM: 0
According to Bioray Biotech Co., Ltd latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Bioray Biotech Co., Ltd from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.